ADVB Advanced Biotherapy Inc
-
Advanced Biotherapy Reported Earnings
Friday, May 15, 2026 · 12:00 AM ET
Advanced Biotherapy (ADVB) reported a loss of $0.38 per share on revenue of $0.00 million for the . .
Advanced Biomed Inc. is a biotechnology company focused on early screening and detection, diagnosis and staging and treatment of cancer. Advanced Biomed Inc. is based in Tainan, Taiwan.
Earnings Whisper Grade
—
Power Rating—
Reported Earnings
($0.38)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth
Reported Revenue
—
Revenue Estimate
—
Revenue Surprise
Revenue Growth—